Pacific Shuanglin Bio-pharmacy Co., LTD reported earnings results for the nine months ended September 30, 2023. For the nine months, the company reported sales was CNY 1,374.81 million compared to CNY 1,493.47 million a year ago. Net income was CNY 326.2 million compared to CNY 349.54 million a year ago.

Basic earnings per share from continuing operations was CNY 0.446 compared to CNY 0.4784 a year ago. Diluted earnings per share from continuing operations was CNY 0.446 compared to CNY 0.478 a year ago.